You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thrombotic microangiopathy (TMA)

Showing 26 - 50 of 967
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thrombotic Disorder Trial (N-acetyl-cysteine, Busulfan, Cytarabine)

Not yet recruiting
  • Thrombotic Disorder
  • (no location specified)
Jun 8, 2023

Hemophilia A Trial in Atlanta (aPCC-emicizumab, FEIBA, rFVIIa)

Not yet recruiting
  • Hemophilia A
  • Atlanta, Georgia
  • +1 more
Jan 5, 2023

Purpura, Thrombocytopenic Trial in Sevilla (Standard clinical practice)

Not yet recruiting
  • Purpura, Thrombocytopenic
  • Standard clinical practice
  • Sevilla, Andalucia, Spain
    Hospital Universitario Virgen del Rocío
Jun 13, 2023

BrazilianDiagnosis of Spinal Muscular Atrophy Treated With

Not yet recruiting
  • Spinal Muscular Atrophies
  • Onasemnogene Abeparvovec
  • (no location specified)
Aug 25, 2023

Atypical Hemolytic Uremic Trial in China (Eculizumab)

Not yet recruiting
  • Atypical Hemolytic Uremic
  • Beijing, China
  • +14 more
May 17, 2023

Atypical Hemolytic Uremic Syndrome Trial in Worldwide (Iptacopan)

Recruiting
  • Atypical Hemolytic Uremic Syndrome
  • Torrance, California
  • +19 more
Aug 10, 2022

Thrombotic Microangiopathies Trial in Amiens, Rouen (Eculizumab administration)

Not yet recruiting
  • Thrombotic Microangiopathies
  • Eculizumab administration
  • Amiens, France
  • +1 more
Jan 18, 2023

Observational Study of Elizaria® in aHUS Patients

Completed
  • Atypical Hemolytic Uremic Syndrome
  • aHUS
  • Kazan, Russian Federation
  • +7 more
Aug 2, 2022

Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)

Active, not recruiting
Has Results
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Ravulizumab
  • Aurora, Colorado
  • +19 more
Nov 16, 2022

Hemolytic-Uremic Syndrome, Membranoproliferative Glomerulonephritis, Healthy Trial in Ranica (C3NEF assay)

Not yet recruiting
  • Hemolytic-Uremic Syndrome
  • +2 more
  • C3NEF assay
  • Ranica, BG, Italy
    Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Aug 9, 2023

CMV Infection, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Letermovir Pill)

Recruiting
  • CMV Infection
  • Hematopoietic Stem Cell Transplantation
  • Letermovir Pill
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Aug 26, 2023

Plasma Exchange on Prognosis of Pregnancy-related Thrombotic

Not yet recruiting
  • Pregnancy-related Thrombotic Microangiopathies
  • plasma exchange
  • (no location specified)
Jun 29, 2021

Atypical Hemolytic-Uremic Syndrome Trial in Worldwide

Recruiting
  • Atypical Hemolytic-Uremic Syndrome
    • Washington, District of Columbia
    • +130 more
    Mar 2, 2022

    Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

    Recruiting
    • Adenine Phosphoribosyltransferase Deficiency
    • +83 more
      • Bristol, South West, United Kingdom
        Zoe Plummer
      Sep 26, 2023

      Haemolytic and Uremic Syndrome Trial in Montpellier (Azithromycin, Placebo (glucose solution 10%))

      Completed
      • Haemolytic and Uremic Syndrome
      • Montpellier, France
        Arnaud de Villeneuve Hospital
      Oct 1, 2021

      Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)

      Not yet recruiting
      • Neuroblastoma
      • Anti Thymocyte Globulin
      • +10 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital, Sun Yat-sen University
      Jun 29, 2022

      Severe Hemophilia A, Moderate Hemophilia A Trial in Worldwide (Emicizumab)

      Recruiting
      • Severe Hemophilia A
      • Moderate Hemophilia A
      • Los Angeles, California
      • +10 more
      Aug 12, 2022

      The Endothelial Cell Dysfunction and Outcome Project for

      Not yet recruiting
      • Hematological Neoplasm
      • Endothelial Dysfunction
      • Sublingual in vivo microscopy with the Glycocheck microscope
      • (no location specified)
      Aug 14, 2022

      Thrombotic Microangiopathies Trial in Worldwide (OMS721)

      Completed
      • Thrombotic Microangiopathies
      • OMS721
      • Duarte, California
      • +24 more
      Jul 1, 2021

      Thrombotic Thrombocytopenic Purpura Trial (Aspirin tablet, Placebo)

      Not yet recruiting
      • Thrombotic Thrombocytopenic Purpura
      • Aspirin tablet
      • Placebo
      • (no location specified)
      Sep 30, 2022

      Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura Trial in Paris (Biological and imaging investigations)

      Completed
      • Thrombotic Microangiopathies
      • Thrombotic Thrombocytopenic Purpura
      • Biological and imaging investigations
      • Paris, France
        Saint Antoine
      Jul 23, 2019

      Improvement of Immunologic and Molecular Techniques for

      Not yet recruiting
      • Acquired Thrombotic Thrombocytopenic Purpura
      • ADAMTS13 Activity Assays
      • (no location specified)
      May 26, 2022

      Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation Trial in Worldwide (busulfan, cyclophosphamide and

      Recruiting
      • Acute Myeloid Leukemia (AML) in Remission
      • Stem Cell Transplantation
      • busulfan, cyclophosphamide and melphalan, BuCyMel
      • clofarabine, fludarabine and busulfan, CloFluBu
      • Brussels, Belgium
      • +16 more
      Jul 25, 2022

      Diagnostic Algorithm to Diagnose Thrombotic Microangiopathies in

      Unknown status
      • Hemolytic-Uremic Syndrome
        • Cartagena, Bolivar, Colombia
          Gestion Salud
        May 30, 2020

        End Stage Renal Disease, Chronic Hepatitis c Trial in Boston (Glecaprevir / Pibrentasvir Oral Tablet [Mavyret])

        Withdrawn
        • End Stage Renal Disease
        • Chronic Hepatitis c
        • Glecaprevir / Pibrentasvir Oral Tablet [Mavyret]
        • Boston, Massachusetts
          Massachusetts General Hospital
        Mar 4, 2022